SCHEMBL29929937

SCHEMBL29929937

COCCOc1ccc(Br)cc1F

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.44
NSD3 Q9BZ95 1/20 0.44
EGFR P00533 1/20 0.41
KDR P35968 1/20 0.41
KDM4E B2RXH2 4/20 0.41
SLC6A4 P31645 2/20 0.41
KMT2A Q03164 1/20 0.41
AAK1 Q2M2I8 2/20 0.40
HPGD P15428 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FBP1 P09467 1/20 0.39
KDM1A O60341 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823347 1.00 NSD2 (0.44) NSD2NSD3EGFRKDRKDM4E
SCHEMBL427426 0.86 KDR (0.40) EGFRKDRKDM4ESLC6A4KMT2A
SCHEMBL5881114 0.84 HPGD (0.55) NSD2NSD3EGFRKDM4ESLC6A4
SCHEMBL578735 0.84 L3MBTL1 (0.43) NSD2NSD3EGFRKDRKDM4E
SCHEMBL31053304 0.83 FBP1 (0.44) KDM4ESLC6A4KMT2AHPGDL3MBTL1
SCHEMBL1516692 0.83 FBP1 (0.44) KDM4ESLC6A4KMT2AHPGDL3MBTL1
SCHEMBL7934151 0.83 ALDH1A1 (0.45) NSD2NSD3KDM4ESLC6A4AAK1
SCHEMBL1311491 0.82 SMN1; SMN2 (0.49) NSD2NSD3EGFRKDRKDM4E
SCHEMBL14402360 0.81 HPGD (0.47) KDM4EKMT2AHPGDL3MBTL1
SCHEMBL7769950 0.81 NSD2 (0.46) NSD2NSD3KDM4ESLC6A4AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843641-B NSD3 inhibitor and preparation method and application thereof 和径医药科技(上海)有限公司 2025-04-25 CN disclosed
CN-117843641-A NSD3 inhibitor and preparation method and application thereof 和径医药科技(上海)有限公司 2024-04-09 CN disclosed
CN-109311887-B Pyrazolo [1,5-a ] pyrimidinecarboxamide compounds and their use in the treatment of medical conditions BIAL研发投资股份有限公司 2022-09-13 CN disclosed